Biomaterial Database

Treatment of interstitial cystitis with intravesical heparin. 1994

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Division of Urology, University of California, San Diego Medical Center.

OBJECTIVE To control the symptoms of interstitial cystitis with chronic self-administered intravesical heparin and determine whether the drug's continued use can sustain remission. METHODS A total of 48 patients were selected to undergo intravesical heparin therapy, 10,000 units in 10 ml sterile water, three times per week for 3 months. For patients who attained a good clinical remission, therapy was available for up to a further 9 months. RESULTS At 3 months 27 of 48 patients (56%) attained good clinical remissions. All were offered continuous therapy and 23 elected for an additional 3 months. Twenty of the 23 continued in remission. Sixteen of these patients elected to have a further 6 months of therapy (12 months total) and 15 of 16 remained in remission. CONCLUSIONS In over half of the patients studied, intravesical heparin controls the symptoms of interstitial cystitis with continued improvement even after one year of therapy.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D003556	Cystitis	Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.	Cystitides
D004334	Drug Administration Schedule	Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.	Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260	Female		Females
D005500	Follow-Up Studies	Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.	Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006493	Heparin	A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.	Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000283	Administration, Intravesical	The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.	Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults

Related Publications

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Intravesical treatment of interstitial cystitis with a heparin analogue.

February 1995, British journal of urology,

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Intravesical heparin: interstitial cystitis (painful bladder syndrome).

November 2013, Hospital pharmacy,

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Interstitial cystitis - intravesical treatment.

May 2019, Revista da Associacao Medica Brasileira (1992),

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Intravesical heparin and peripheral neuromodulation on interstitial cystitis.

January 2005, Urologia internationalis,

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Chronic interstitial cystitis. Successful treatment with intravesical idocaine.

December 1992, Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences,

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Interstitial cystitis intravesical therapy.

July 2017, Translational andrology and urology,

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Interstitial cystitis treated with intravesical doxorubicin.

August 1990, Urology,

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

[Intravesical therapy of interstitial cystitis].

November 2000, Der Urologe. Ausg. A,

C L Parsons, and T Housley, and J D Schmidt, and D Lebow

Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin.

January 2008, Urology,